Professional Documents
Culture Documents
Date Collected: 03/28/2022 Date Received: 03/29/2022 Date Reported: 03/29/2022 Fasting: Not Given
SARS-CoV-2, NAA
Test Current Result and Flag Previous Result and Date Units Reference Interval
SARS-CoV-2, NAA 01
Not Detected Not Detected 03/29/2022 Not Detected
This nucleic acid amplification test was developed and its performance
characteristics determined by LabCorp Laboratories. Nucleic acid
amplification tests include RT-PCR and TMA. This test has not been
FDA cleared or approved. This test has been authorized by FDA under
an Emergency Use Authorization (EUA). This test is only authorized
for the duration of time the declaration that circumstances exist
justifying the authorization of the emergency use of in vitro
diagnostic tests for detection of SARS-CoV-2 virus and/or diagnosis
of COVID-19 infection under section 564(b)(1) of the Act, 21 U.S.C.
360bbb-3(b) (1), unless the authorization is terminated or revoked
sooner.
When diagnostic testing is negative, the possibility of a false
negative result should be considered in the context of a patient's
recent exposures and the presence of clinical signs and symptoms
consistent with COVID-19. An individual without symptoms of COVID-19
and who is not shedding SARS-CoV-2 virus would expect to have a
negative (not detected) result in this assay.
SARS-CoV-2, NAA 2 DAY TAT 02 Performed Performed 03/29/2022
Disclaimer
The Previous Result is listed for the most recent test performed by Labcorp in the past 3 years where there is sufficient patient demographic
data to match the result to the patient.
Icon Legend
Out of reference range Critical or Alert
Performing Labs
01: TG - LabCorp RTP 1912 TW Alexander Drive, RTP, NC, 27709-0150 Dir: Anjen Chenn, MDPhD
02: TA - LabCorp Tampa 5610 W LaSalle Street, Tampa, FL, 33607-1770 Dir: Sean Farrier, MD
For Inquiries, the physician can contact Branch: 800-877-5227 Lab: 800-877-5227
©2021 Laboratory Corporation of America® Holdings This document contains private and confidential health information protected by state and federal law.
All Rights Reserved - Enterprise Report Version 2.00 If you have received this document in error please call 800-877-5227